Clinical Trial Update: A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates decitabine in combination with escalating doses of rapamycin in patients with relapsed or refractory acute myeloid leukemia; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• Rapamune (sirolimus)

Snippet

Sponsor: University of Rochester | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED